Effect of Thiazolidinedione Treatment on Progression of Subclinical Atherosclerosis in Premenopausal Women at High Risk for Type 2 Diabetes
Anny H. Xiang(Kaiser Permanente), Thomas A. Buchanan(Keck Hospital of USC), Sylvia Tan(University of California, Los Angeles), Liu Ci-hua(Jet Propulsion Laboratory), Ruth Peters(University of Southern California), Chengwei Wang(University of California, Los Angeles), Chaoran Liu(Chinese University of Hong Kong), César Ochoa(University of Southern California), Siri L. Kjos, Stanley P. Azen(Jet Propulsion Laboratory), Jose Goico(University of Southern California), Howard N. Hodis(University of Southern California), Aura Marroquin(University of Southern California)
Cited by 68
Related Papers
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2018|1.6k
Estrogen in the Prevention of Atherosclerosis
|Annals of Internal Medicine|2001|687
Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS–Cognitive and Affective Study
|PLoS Medicine|2015|481
Understanding the gut microbiota and sarcopenia: a systematic review
|Journal of Cachexia Sarcopenia and Muscle|2021|340
Arterial Imaging Outcomes and Cardiovascular Risk Factors in Recently Menopausal Women
|Annals of Internal Medicine|2014|335